MCK McKesson Corporation

XNYS Up Alert

Health Care

· How we analyze

About the company

McKesson is a US pharmaceutical wholesaler. The company distributes medicines to pharmacies and hospitals, supplies medical products to doctors’ offices and offers software and services for pharmacies and oncology practices. As of Oct 13, 2026

Fact sheet (from the annual report) Wholesale of drugs and drugstore products · Irving, USA

McKesson is a healthcare services company that works with pharmaceutical companies, healthcare providers, pharmacies, manufacturers and government agencies. The North American Pharmaceutical segment distributes branded drugs, generics, specialty drugs, biosimilars and over-the-counter products to pharmacies, hospitals and physicians in the United States and Canada. The Oncology & Multispecialty segment comprises specialty drug distribution and infusion services and supports a network of physician-led community oncology practices. Prescription Technology Solutions uses technology services such as electronic prior authorizations and price transparency to make it easier for patients to access affordable medicines. Another segment supplies consumables such as gloves, syringes and wound care to doctors’ offices, ambulatory surgery centers and post-acute care facilities and is to be separated.

Automatically summarized from SEC annual report (10-K, filed May 8, 2026) (website of the US Securities and Exchange Commission) · reviewed Oct 14, 2026

Price performance at a glance

Last 30 trading days
  • Today −2.6%
  • 7 days −6.1%
  • 30 days +11.6%
  • 1 year +19.2%
Day range (last trading day)
0.0%Price at 2% of the range+2.7%
52-week range
−25.2%Price at 79% of the range+6.5%
Distance from the all-time high
−6.1%

Our own calculation from the exchange’s daily candles, as of Oct 27, 2026. “All-time” applies since the start of this series, not to the whole market. Changes in percent; the TradingView chart shows prices. “Today” = change of the last trading day versus the previous day. Not investment advice.

Double bottom · Analysis method

The price of MCK is currently in no zone of this method. The check runs daily after the market close.

Whether a price will soon reach a zone, you see from Watcher. Plans and pricing

How the zone is formed

What is this? The price has formed two similarly deep lows and broken above the neckline between them. This is seen as a sign that the downward move is ending.

Buy zone: retest of the neckline (up to 1 ATR above it). Stop: just below the second low. Targets: height of the pattern from the neckline (1.0× and 1.618×).

The pattern is valid for at most 15 trading days and expires if the price falls below the stop. This is a calculated analysis, not a forecast and not a call to buy. Risk notice and investment advice

Load chart from TradingView

This transfers data (including your IP address) to TradingView, also to the USA. More in the Privacy policy.

Symbol on TradingView: NYSE:MCK

Save zone

With a free account: save the buy zone shown for yourself (stop and targets from Watcher). It stays visible even if the zone changes later. Log in · Sign up

Fundamental analysis

McKesson Corporation · Sector Health Care · amounts in USD

Information only – does not affect our buy zones, not investment advice. Source: SEC filings, As of May 8, 2026.

In short

  • Light green: Revenue grew over 5 years (+11.1% per year), at least as fast as the sector median.
  • Light yellow: Net margin 1.2%, below the sector median (12.9%).
  • Light yellow: Profit in 9 of 10 fiscal years.

Summarized from the lights below. Describes the reported figures – not a recommendation to buy or sell.

RevenueNet income Net margin (below) in USD
  1. Fiscal year 2017 (Apr 1, 2016 – Mar 31, 2017): Revenue 198.5B USD · Net income 5.1B USD · Net margin 2.6%
  2. Fiscal year 2018 (Apr 1, 2017 – Mar 31, 2018): Revenue 208.4B USD · Net income 67.0M USD · Net margin 0.0%
  3. Fiscal year 2019 (Apr 1, 2018 – Mar 31, 2019): Revenue 214.3B USD · Net income 34.0M USD · Net margin 0.0%
  4. Fiscal year 2020 (Apr 1, 2019 – Mar 31, 2020): Revenue 231.1B USD · Net income 900.0M USD · Net margin 0.4%
  5. Fiscal year 2021 (Apr 1, 2020 – Mar 31, 2021): Revenue 238.2B USD · Net income −4.5B USD · Net margin −1.9%
  6. Fiscal year 2022 (Apr 1, 2021 – Mar 31, 2022): Revenue 264.0B USD · Net income 1.1B USD · Net margin 0.4%
  7. Fiscal year 2023 (Apr 1, 2022 – Mar 31, 2023): Revenue 276.7B USD · Net income 3.6B USD · Net margin 1.3%
  8. Fiscal year 2024 (Apr 1, 2023 – Mar 31, 2024): Revenue 309.0B USD · Net income 3.0B USD · Net margin 1.0%
  9. Fiscal year 2025 (Apr 1, 2024 – Mar 31, 2025): Revenue 359.1B USD · Net income 3.3B USD · Net margin 0.9%
  10. Fiscal year 2026 (Apr 1, 2025 – Mar 31, 2026): Revenue 403.4B USD · Net income 4.8B USD · Net margin 1.2%

Fiscal year 2026 (Apr 1, 2025 – Mar 31, 2026): Revenue 403.4B USD · Net income 4.8B USD · Net margin 1.2%

Key figures with traffic lights

Each light follows a simple, disclosed rule. The comparison is with the sector median of all 63 symbols in the Health Care sector on our list (current members of the S&P 500 and other lists).

Revenue growth

Light green: above sector

+11.1% per year, last 5 years

Sector Health Care: median +7.8% (60 symbols)

What does this mean? Revenue: over 5 years it grew by 11.1% per year on average – at least as fast as the median company in the sector (+7.8%).

Light rule: Green: grows at least as fast as the sector median (without a sector comparison: grows) · Yellow: grows more slowly · Red: shrinks.

Net income (total)

Light gray: not computable

– per year, last 5 years

Sector Health Care: median +7.5% (46 symbols)

per share: not computable (loss in the first or last year)

What does this mean? There was a loss in the first or last year. An annual growth rate cannot be calculated meaningfully then.

Light rule: Green: grows at least as fast as the sector median (without a sector comparison: grows) · Yellow: grows more slowly · Red: shrinks.

Net margin

Light yellow: below sector

1.2% last fiscal year

Sector Health Care: median 12.9% (63 symbols)

What does this mean? Of every 100 USD in revenue, 1.18 USD remained as profit – less than the median company in the sector (12.9%). Five years ago the margin was −1.9%.

Light rule: Green: at least the sector median (without a sector comparison: profit) · Yellow: profit, but below the median · Red: loss.

Debt / equity

Light gray: negative equity

– latest balance sheet

Sector Health Care: median 0.66 (40 symbols)

What does this mean? Equity is negative (e.g. due to share buybacks). A debt-to-equity ratio cannot be formed meaningfully then.

Light rule: Green: at most the sector median · Yellow: up to twice the median · Red: more than twice · Gray: without a sector comparison.

Payout ratio

Light green: covered

8% Dividend / earnings per share

Sector Health Care: median 28% (31 symbols)

What does this mean? Of every 1 USD of earnings per share, 0.08 USD went to shareholders as a dividend. The rest stays in the company. Median company in the sector: 28%.

Light rule: Green: up to 60% of earnings · Yellow: up to 100% · Red: more than earnings or a dividend despite a loss · Gray for real estate (REITs). The sector median is for comparison only.

Profitable years

Light yellow: 1 loss year

9 of 10 fiscal years with a profit

What does this mean? In 9 of the last 10 fiscal years the bottom line showed a profit. One year ended with a loss.

Light rule: Green: profit in every year · Yellow: one loss year · Red: several loss years (at least 3 years needed).

Last fiscal year and 13F

Information, not a trading signal · Source: SEC EDGAR
Revenue (FY)
403.4B USD
Revenue vs. prior year
+12.4%
Net income (FY)
4.8B USD
Net income vs. prior year
+44.5%
EPS (FY)
38.38 USD
13F funds with a position
2 of 9
Funds vs. prior quarter
+1
Shares held vs. prior quarter
+1,095.1%
Fiscal year to Mar 31, 2026 · 10-K filed May 8, 2026 · Price-based figures (P/E, P/S, dividend yield, market cap) only when logged in. · Values as first reported; debt = reported financial debt (US GAAP: long-term). 13F: reporting date Jun 30, 2026, 9 tracked funds have filed (latest Aug 14, 2026), filed with up to 45 days of delay. Stock positions only; comparison with Mar 31, 2026 only across funds that filed for both quarters.
All figures as a table
Fiscal years (amounts in USD, per share in USD)
YearEndRevenueNet income MarginEarnings per shareDividend per sharePayout
2026Mar 31, 2026 403.4B4.8B 1.2% 38.38 3.17 8%
2025Mar 31, 2025 359.1B3.3B 0.9% 25.72 2.75 11%
2024Mar 31, 2024 309.0B3.0B 1.0% 22.39 2.40 11%
2023Mar 31, 2023 276.7B3.6B 1.3% 25.03 2.09 8%
2022Mar 31, 2022 264.0B1.1B 0.4% 7.23 1.83 25%
2021Mar 31, 2021 238.2B−4.5B −1.9% −28.26 1.67 –
2020Mar 31, 2020 231.1B900.0M 0.4% 4.95 1.62 33%
2019Mar 31, 2019 214.3B34.0M 0.0% 0.17 1.51 888%
2018Mar 31, 2018 208.4B67.0M 0.0% 0.32 1.30 406%
2017Mar 31, 2017 198.5B5.1B 2.6% 22.73 1.12 5%
Quarters (amounts in USD, per share in USD)
QuarterEndRevenueNet income MarginEarnings per shareDividend per sharePayout
Q2/26Jun 30, 2026 105.4B614.0M 0.6% 5.15 0.82 16%
Q1/26*Mar 31, 2026 96.3B1.7B 1.7% – 0.82 –
Q4/25Dec 31, 2025 106.2B1.2B 1.1% 9.59 0.82 9%
Q3/25Sep 30, 2025 103.2B1.1B 1.1% 8.92 0.82 9%
Q2/25Jun 30, 2025 97.8B784.0M 0.8% 6.25 0.71 11%
Q1/25*Mar 31, 2025 90.8B1.3B 1.4% – 0.71 –
Q4/24Dec 31, 2024 95.3B879.0M 0.9% 6.95 0.71 10%
Q3/24Sep 30, 2024 93.7B241.0M 0.3% 1.87 0.71 38%
Q2/24Jun 30, 2024 79.3B915.0M 1.2% 7.00 0.62 9%
Q1/24*Mar 31, 2024 76.4B791.0M 1.0% – 0.62 –
Q4/23Dec 31, 2023 80.9B589.0M 0.7% 4.42 0.62 14%
Q3/23Sep 30, 2023 77.2B664.0M 0.9% 4.92 0.62 13%

* Q4 derived: fiscal year minus the 9-month value (EPS cannot be derived this way); may be distorted by restatements.

How we calculate: values as first reported to the SEC (later corrections are left out), a fixed order of reporting tags per figure, partial sums are never added up. Growth per year over 5 years (otherwise 3 years). Quarters are labeled by the calendar quarter in which they end.

Insiders

All insider transactions
Insider purchases and sales on the market over 3, 6 and 12 months
PeriodPurchasesSalesNet
3 months $00 people $1.2M3 people −$1.2M
6 months $00 people $24.8M7 people −$24.8M
12 months $00 people $29.1M8 people −$29.1M

Latest transactions

  • Oct 15, 2026 Fraga Francisco Officer Open-market sale · 10b5-1 plan 800 shares · $797.1K · SEC
  • Sep 8, 2026 Rutledge Napoleon B JR Officer Open-market sale · 10b5-1 plan 111 shares · $99.0K · SEC
  • Aug 10, 2026 Lerman Bradley E Director Open-market sale 301 shares · $268.6K · SEC
  • Jul 7, 2026 Tyler Brian S. Chief executive (CEO), Director Open-market sale · 10b5-1 plan 8,463 shares · $6.7M · SEC
  • Jun 17, 2026 Tyler Brian S. Chief executive (CEO), Director Open-market sale · 10b5-1 plan 8,463 shares · $6.6M · SEC
  • Jun 9, 2026 Tyler Brian S. Chief executive (CEO), Director Open-market sale · 10b5-1 plan 4,929 shares · $3.8M · SEC

Source: mandatory filings with the SEC (Form 4), open-market purchases and sales only. General information, not investment advice.

Trend score +70

Price vs. EMA 50+15
Price vs. EMA 200+15
EMA 50 vs. EMA 200+20
ADX (trend strength)+15
Highs and lows-10
Relative strength+15

Volatility and trend strength

ADX 14 (trend strength)29.6
Rel. strength 60 d+15.7%

ATR and moving averages as price values only when logged in.

More stocks from Health Care

All symbols in this sector

News

Latest news

Posts

No posts on MCK yet – log in to join the discussion.

Posts are opinions of users and only visible after logging in. Community rules

Set alert: MCK

Alerts with a free account: we send you an email as soon as the price moves above or below your level, reaches the buy zone or the buy zone becomes invalid.

Checked after every data update: crypto hourly (buy zones every 4 hours), stocks twice a day, precious metals every 4 hours on trading days, extended universe weekly – not in real time.

Log in Sign up free

↑ ↓ select · Enter open · Esc close